1.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 52% shares - Simply Wall St
Y.D. More Investments Ltd Reduces Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud - Grizzly Reports
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 Shares - MarketBeat
Opko health CEO Phillip Frost buys $70,060 in stock By Investing.com - Investing.com Australia
Opko health CEO Phillip Frost buys $70,060 in stock - MSN
Clinical Laboratory Tests Market Generated Opportunities, - openPR
Clinical Laboratory Tests Market Key Players AnalysisARUP - openPR
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Billionaire Phillip Frost's health care company settles case with federal government - The Business Journals
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Insider Monkey
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
3 Stocks That Wall Street Insiders Can't Stop Buying - MSN
BioReference faces $704,349 fine for medically unnecessary blood tests - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock - MSN
OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com
Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Australia
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today
BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law
Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com South Africa
Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in Stock - MarketBeat
Opko Health Engages Investors at J.P. Morgan Conference - TipRanks
OPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.com - MarketBeat
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Could Signal Some Risk - Simply Wall St
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Opko Health stock buy rating reaffirmed, steady target on clinical trial - Investing.com Canada
OPKO Health's (OPK) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
OPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr - GlobeNewswire
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):